
Closing Bell Overtime: 11/3/25
Closing Bell
00:00
Why did Kimberly-Clark buy Kenvue and what happened to its stock?
Reporters discuss Kimberly-Clark's $49 billion Kenvue acquisition and shareholders' negative reaction amid Tylenol controversy.
Play episode from 37:12
Transcript


